Find policies, billing codes, payers, states, and providers
CPT 54800: Needle Biopsy of Epididymis for Diagnostic Evaluation
CPT code 54800 denotes a percutaneous needle biopsy of the epididymis performed to obtain tissue for diagnostic pathology. This procedure is relevant nationally for urology and surgical practices that evaluate unexplained scrotal masses, suspected epididymal infections, or possible neoplasms. Accurate coding supports appropriate clinical documentation, care coordination, and payer adjudication for a targeted diagnostic procedure. Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, United Healthcare, and Medicare. Readers will find a concise clinical description, typical sites of service, associated diagnostic contexts, and related procedural codes used in differential procedural reporting. The publication outlines common coding relationships to procedures such as hydrocele excision and aspiration and vasectomy-related services to help clarify coding choices during episodes of care. The content also summarizes expected payer coverage considerations and commonly used billing modifiers for procedural reporting. This resource is intended for coding professionals, billing managers, and clinicians seeking a clear reference on clinical intent and billing context for CPT code 54800 in national practice settings.
Customize your policy alerts
Sign up for cpt 54800 policy alerts
Get alerted when payer policies referencing 54800 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 54800 describes a needle biopsy of the epididymis. The procedure involves percutaneous needle sampling of epididymal tissue for diagnostic evaluation of epididymal conditions. The primary clinical purpose is to obtain tissue for pathology to help diagnose infectious, inflammatory, or neoplastic processes of the epididymis.
Service type: Diagnostic biopsy procedure
Typical site of service: Ambulatory surgical center or hospital outpatient surgical unit; office-based procedure if performed with appropriate clinical resources
National Reimbursement Benchmarks
Medicare's mean allowed rate of $113.10 sits well below BUCA's average commercial mean of $434.50, indicating a substantial gap between federal reimbursement and this commercial benchmark for CPT 54800. The commercial mean for BUCA is nearly four times Medicare, reflecting a lender-side commercial market that pays materially higher averages for this code.
Dispersion measured by the interquartile range (P75 minus P25) varies notably: Blue Cross Blue Shield has the widest IQR at $480.10 ($785.60 - $380.50), followed by BUCA at $252.30 ($547.70 - $262.40) and UnitedHealth Group at $137.40 ($277.90 - $140.50). Aetna and Cigna show tighter spreads of $95.40 ($129.90 - $35.00) and $144.00 ($283.50 - $139.50), respectively, making Aetna the tightest among these payers.